Beverly A Goldberg, MD | |
275 Varnum Ave, Suite 203, Lowell, MA 01854-2109 | |
(978) 934-9220 | |
(978) 453-7771 |
Full Name | Beverly A Goldberg |
---|---|
Gender | Female |
Speciality | Pulmonary Disease |
Experience | 33 Years |
Location | 275 Varnum Ave, Lowell, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154316693 | NPI | - | NPPES |
41500 | Other | MA | FALLON |
077723 | Other | MA | TUFTS |
PI12041160 | Other | MA | MULTIPLAN |
02551031 | Medicaid | NY | |
2803598 | Other | MA | AETNA |
J14721 | Other | MA | BCBS |
23740 | Other | MA | HARVARD PILGRIM |
976462 | Other | MA | NETWORK HEALTH |
0024274 | Other | MA | NEIGHBORHOOD HEALTH PLAN |
3129764 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | 77723 (Massachusetts) | Secondary |
207RP1001X | Internal Medicine - Pulmonary Disease | 77723 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lowell General Hospital | Lowell, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lgh Medical Group, Inc. | 3173626751 | 101 |
News Archive
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
Warner Chilcott plc today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (advised by CCMP Capital) and Thomas H. Lee Partners, L.P., certain other institutional investors and members of the Company's senior management. The offering is being conducted as a public offering pursuant to an effective shelf registration statement under the Securities Act of 1933. The Company will not receive any proceeds from the sale of the shares but will pay the expenses of the offering.
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it has received approval from the Food and Drug Administration to initiate patient enrollment in the EXCELLA III clinical trial in the United States at up to 50 institutions with conditions to be addressed in parallel.
Children with reading difficulties should be more thoroughly screened for hearing problems, a new report by Coventry University academics has said.
Most people know a colonoscopy requires some preparation by the patient. Now, a Mayo Clinic physician suggests an additional step to lower the risk of colorectal cancer: Ask for your doctor's success rate detecting easy-to-miss polyps called adenomas.
› Verified 1 days ago
Entity Name | Lgh Medical Group, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174698385 PECOS PAC ID: 3173626751 Enrollment ID: O20070320000453 |
News Archive
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
Warner Chilcott plc today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (advised by CCMP Capital) and Thomas H. Lee Partners, L.P., certain other institutional investors and members of the Company's senior management. The offering is being conducted as a public offering pursuant to an effective shelf registration statement under the Securities Act of 1933. The Company will not receive any proceeds from the sale of the shares but will pay the expenses of the offering.
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it has received approval from the Food and Drug Administration to initiate patient enrollment in the EXCELLA III clinical trial in the United States at up to 50 institutions with conditions to be addressed in parallel.
Children with reading difficulties should be more thoroughly screened for hearing problems, a new report by Coventry University academics has said.
Most people know a colonoscopy requires some preparation by the patient. Now, a Mayo Clinic physician suggests an additional step to lower the risk of colorectal cancer: Ask for your doctor's success rate detecting easy-to-miss polyps called adenomas.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Beverly A Goldberg, MD 275 Varnum Ave, Suite 203, Lowell, MA 01854-2109 Ph: (978) 934-9220 | Beverly A Goldberg, MD 275 Varnum Ave, Suite 203, Lowell, MA 01854-2109 Ph: (978) 934-9220 |
News Archive
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
Warner Chilcott plc today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (advised by CCMP Capital) and Thomas H. Lee Partners, L.P., certain other institutional investors and members of the Company's senior management. The offering is being conducted as a public offering pursuant to an effective shelf registration statement under the Securities Act of 1933. The Company will not receive any proceeds from the sale of the shares but will pay the expenses of the offering.
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it has received approval from the Food and Drug Administration to initiate patient enrollment in the EXCELLA III clinical trial in the United States at up to 50 institutions with conditions to be addressed in parallel.
Children with reading difficulties should be more thoroughly screened for hearing problems, a new report by Coventry University academics has said.
Most people know a colonoscopy requires some preparation by the patient. Now, a Mayo Clinic physician suggests an additional step to lower the risk of colorectal cancer: Ask for your doctor's success rate detecting easy-to-miss polyps called adenomas.
› Verified 1 days ago
Alexandra Miniati, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 275 Varnum Ave Riverside Medical Group, Ste 201, Lowell, MA 01854 Phone: 978-452-9700 Fax: 978-441-6075 | |
Dr. Cynthia Lynn Manning, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6439 | |
Mrs. Frances M Morse, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 275 Varnum Ave, Ste 101, Lowell, MA 01854 Phone: 978-459-0531 Fax: 978-459-8389 | |
Mrs. Sara Larson Clay, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 275 Varnum Ave, Ste 201, Lowell, MA 01854 Phone: 978-452-9700 Fax: 978-441-6075 | |
Riad Ettunsi, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 295 Varnum Ave, Lowell, MA 01854 Phone: 978-937-6000 | |
Peter S Bradshaw, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 77 E Merrimack St, Suite 15, Lowell, MA 01852 Phone: 978-459-3341 | |
Seema Sahib, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 295 Varnum Ave # General, Lowell, MA 01854 Phone: 978-937-6439 |